-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AVX-901 in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AVX-901 in Metastatic Breast Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AVX-901 in Metastatic Breast Cancer Drug Details: AVX-901 (HER2 VRP vaccine)...
-
Product Insights
Eastern Equine Encephalitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Eastern Equine Encephalitis Pipeline Drugs Market Report Overview The Eastern Equine Encephalitis pipeline drugs market research report provides comprehensive information on the Eastern Equine Encephalitis targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also reviews key players involved in Eastern Equine Encephalitis targeted therapeutics development with respective active and dormant or discontinued projects.
-
Product Insights
Western Equine Encephalitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Western Equine Encephalitis Drugs Development Market Report Overview Western equine encephalitis is a disease that is spread to humans by infected mosquitoes. Western equine encephalitis is caused by the western equine encephalitis virus, an arbovirus. Symptoms range from mild to severe and may include only fever and headache to encephalitis with delirium, disorientation, or coma. The western equine encephalitis pipeline drugs market research report provides comprehensive information on the therapeutics under development for western equine encephalitis, complete with analysis by...
-
Product Insights
Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Colorectal Cancer Pipeline Drugs Market Overview Colorectal cancer starts in the colon or the rectum. It begins as a growth called a polyp on the inner lining of the colon or rectum. Symptoms include abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, change in bowel habits, narrow stools, and weight loss with no known reasons. Risk factors for colorectal cancer include smoking, heavy alcohol use, inflammatory bowel disease (IBD), and family history. Treatment includes...
-
Product Insights
Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Melanomas usually occur on the skin but can arise in other locations where neural crest cells migrate, such as in the gastrointestinal tract or brain. It is more common in women than in men. The Melanoma pipeline market research report provides comprehensive information on the therapeutics under development for Melanoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AVX-101
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry AVX-101 Drug Details AVX-101 (Alphavirus Replicon HIV-1 Subtype C Gag Vaccine) is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AVX-901
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry AVX-901 Drug Details AVX-901 (HER2 VRP vaccine) is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AVX-601
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry AVX-601 Drug Details AVX-601 is under development against of viral infections caused by cytomegalovirus....
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AVX-502
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry AVX-502 Drug Details AVX-502 is under development for the prevention of H3N2 seasonal influenza...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – influenza [strains A/H5N1 + A/H1N1] vaccine
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry influenza [strains A/H5N1 + A/H1N1] vaccine Drug Details The vaccine candidate is under development...